Hospitals & Healthcare Pressreleases

This section covers the managerial aspects in the Healthcare industry.

(ASCO2020) Ascentage Pharma Presents Latest Clinical Data of Apoptosis Targeting Drug Candidates, Showing Promising Clinical Effects with Combination Therapies

Sunday, May 31, 2020
PR NEWSWIRE

SUZHOU China and ROCKVILLE Md May PRNewswire Ascentage Pharma HK a globally focused clinicalstage biotechnology company engaged in developing novel therapies for cancers chronic hepatitis B CHB and agerelated diseases today announced that the comp...

Taiho Oncology Announces Presentation of Data for Futibatinib in Advanced Intrahepatic Cholangiocarcinoma at 2020 ASCO Meeting

Sunday, May 31, 2020
PR NEWSWIRE

PRINCETON NJ May PRNewswire Taiho Oncology Inc today announced efficacy and safety results of an interim analysis of FOENIXCCA a singlearm multicenter Phase study evaluating futibatinib TAS in patients with intrahepatic cholangiocarcinoma iCCA...

BioMarin Provides Highlights of 4 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

Sunday, May 31, 2020
PR NEWSWIRE

SAN RAFAEL Calif May PRNewswire BioMarin Pharmaceutical Inc NASDAQ BMRN announced today an update to its previously reported results of an openlabel Phase study of valoctocogene roxaparvovec an investigational gene therapy treatment for adults wi...

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

Sunday, May 31, 2020
PR NEWSWIRE

SUZHOU China May PRNewswire Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology autoimmune metabolic and other major diseas...

Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Sunday, May 31, 2020
PR NEWSWIRE

SUZHOU China May PRNewswire Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines jointly announced with Eli Lilly and Company Lilly NYSE LLY the results o...

Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin\'s Lymphoma

Sunday, May 31, 2020
PR NEWSWIRE

SUZHOU China May PRNewswire Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines jointly announced with Eli Lilly and Company Lilly NYSE LLY the research r...

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

Sunday, May 31, 2020
PR NEWSWIRE

SUZHOU China May PRNewswire Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology autoimmune metabolic and other major disease...

Global Donors And Top Aid Officials Gather Virtually For Yemen Pledging Event

Sunday, May 31, 2020
PR NEWSWIRE

RIYADH Saudi Arabia May PRNewswire The Kingdom of Saudi Arabia is set to become the largest consistent donor to Yemen during the upcoming HighLevel Pledging Event for the Humanitarian Crisis in Yemen on Tuesday

MimiVax Phase 2 study of SurVaxM in combination with pembrolizumab opens for recurrent glioblastoma patients

Saturday, May 30, 2020
PR NEWSWIRE

BUFFALO NY May PRNewswire MimiVax LLC a clinicalstage biotechnology company in Buffalo NY USA developing immunotherapeutics for cancer and autoimmune diseases announced a clinical collaboration to assess the combination of SurVaxM MimiVax and pembr...

Vision Group Holdings Announces Voluntary Reorganization In U.S. Under Chapter 11

Saturday, May 30, 2020
PR NEWSWIRE

WEST PALM BEACH Fla May PRNewswire LVI Intermediate and of its affiliates including the Laser Vision Institute and TLC Laser Eye Center brands doing business as Vision Group Holdings today filed for voluntary protection from creditors in Delaware...